While higher density of tumor-infiltrating CD8+ T cells is consistently associated with favorable clinical outcomes in various solid tumors, including BC (3, 4), the functional role and clinical significance of tumor-infiltrating B lymphocytes (TIL-B) is far less clear (5). This evidence concerns the gene CD8A and breast cancer.